S&P 500   3,236.50 (-2.50%)
DOW   26,805.31 (-3.08%)
QQQ   263.67 (-1.20%)
AAPL   106.92 (+0.07%)
MSFT   199.57 (-0.41%)
FB   246.80 (-2.27%)
GOOGL   1,423.32 (-1.91%)
AMZN   2,891.57 (-2.14%)
NVDA   490.49 (+0.60%)
TSLA   440.96 (-0.27%)
BABA   270.89 (-0.56%)
CGC   15.57 (-4.83%)
GE   6.25 (-9.16%)
MU   48.87 (-3.69%)
AMD   76.46 (+2.04%)
T   28.31 (-2.14%)
F   6.86 (-5.12%)
ACB   6.34 (-2.91%)
GILD   63.61 (-2.21%)
NFLX   478.96 (+1.92%)
DIS   124.37 (-3.31%)
BAC   24.11 (-4.36%)
BA   156.61 (-2.81%)
S&P 500   3,236.50 (-2.50%)
DOW   26,805.31 (-3.08%)
QQQ   263.67 (-1.20%)
AAPL   106.92 (+0.07%)
MSFT   199.57 (-0.41%)
FB   246.80 (-2.27%)
GOOGL   1,423.32 (-1.91%)
AMZN   2,891.57 (-2.14%)
NVDA   490.49 (+0.60%)
TSLA   440.96 (-0.27%)
BABA   270.89 (-0.56%)
CGC   15.57 (-4.83%)
GE   6.25 (-9.16%)
MU   48.87 (-3.69%)
AMD   76.46 (+2.04%)
T   28.31 (-2.14%)
F   6.86 (-5.12%)
ACB   6.34 (-2.91%)
GILD   63.61 (-2.21%)
NFLX   478.96 (+1.92%)
DIS   124.37 (-3.31%)
BAC   24.11 (-4.36%)
BA   156.61 (-2.81%)
S&P 500   3,236.50 (-2.50%)
DOW   26,805.31 (-3.08%)
QQQ   263.67 (-1.20%)
AAPL   106.92 (+0.07%)
MSFT   199.57 (-0.41%)
FB   246.80 (-2.27%)
GOOGL   1,423.32 (-1.91%)
AMZN   2,891.57 (-2.14%)
NVDA   490.49 (+0.60%)
TSLA   440.96 (-0.27%)
BABA   270.89 (-0.56%)
CGC   15.57 (-4.83%)
GE   6.25 (-9.16%)
MU   48.87 (-3.69%)
AMD   76.46 (+2.04%)
T   28.31 (-2.14%)
F   6.86 (-5.12%)
ACB   6.34 (-2.91%)
GILD   63.61 (-2.21%)
NFLX   478.96 (+1.92%)
DIS   124.37 (-3.31%)
BAC   24.11 (-4.36%)
BA   156.61 (-2.81%)
S&P 500   3,236.50 (-2.50%)
DOW   26,805.31 (-3.08%)
QQQ   263.67 (-1.20%)
AAPL   106.92 (+0.07%)
MSFT   199.57 (-0.41%)
FB   246.80 (-2.27%)
GOOGL   1,423.32 (-1.91%)
AMZN   2,891.57 (-2.14%)
NVDA   490.49 (+0.60%)
TSLA   440.96 (-0.27%)
BABA   270.89 (-0.56%)
CGC   15.57 (-4.83%)
GE   6.25 (-9.16%)
MU   48.87 (-3.69%)
AMD   76.46 (+2.04%)
T   28.31 (-2.14%)
F   6.86 (-5.12%)
ACB   6.34 (-2.91%)
GILD   63.61 (-2.21%)
NFLX   478.96 (+1.92%)
DIS   124.37 (-3.31%)
BAC   24.11 (-4.36%)
BA   156.61 (-2.81%)
Log in
NASDAQ:KIDS

Orthopediatrics Stock Forecast, Price & News

$40.77
-2.68 (-6.17 %)
(As of 09/21/2020 02:18 PM ET)
Add
Compare
Today's Range
$40.59
Now: $40.77
$42.91
50-Day Range
$42.19
MA: $48.82
$55.41
52-Week Range
$32.21
Now: $40.77
$55.98
Volume6,812 shs
Average Volume139,486 shs
Market Capitalization$797.01 million
P/E RatioN/A
Dividend YieldN/A
Beta0.72
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard. It offers trauma and deformity procedures; scoliosis procedures for the treatment of spinal deformity; and sports medicine procedures. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2007 and is headquartered in Warsaw, Indiana.
Read More
Orthopediatrics logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.53 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:KIDS
CUSIPN/A
Phone574-268-6379

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$72.55 million
Book Value$8.51 per share

Profitability

Net Income$-13,730,000.00

Miscellaneous

Employees80
Market Cap$797.01 million
Next Earnings Date11/5/2020 (Estimated)
OptionableNot Optionable
$40.77
-2.68 (-6.17 %)
(As of 09/21/2020 02:18 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive KIDS News and Ratings via Email

Sign-up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Orthopediatrics (NASDAQ:KIDS) Frequently Asked Questions

How has Orthopediatrics' stock been impacted by Coronavirus (COVID-19)?

Orthopediatrics' stock was trading at $39.75 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, KIDS shares have increased by 2.6% and is now trading at $40.77.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Orthopediatrics?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthopediatrics in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Orthopediatrics
.

When is Orthopediatrics' next earnings date?

Orthopediatrics is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Orthopediatrics
.

How were Orthopediatrics' earnings last quarter?

Orthopediatrics Corp (NASDAQ:KIDS) released its quarterly earnings data on Tuesday, May, 5th. The company reported ($0.30) EPS for the quarter, missing the Zacks' consensus estimate of ($0.25) by $0.05. The business earned $16.36 million during the quarter, compared to analyst estimates of $16.95 million. Orthopediatrics had a negative return on equity of 13.25% and a negative net margin of 32.28%.
View Orthopediatrics' earnings history
.

What price target have analysts set for KIDS?

6 Wall Street analysts have issued 12 month price targets for Orthopediatrics' shares. Their forecasts range from $48.00 to $57.00. On average, they expect Orthopediatrics' stock price to reach $53.00 in the next year. This suggests a possible upside of 30.0% from the stock's current price.
View analysts' price targets for Orthopediatrics
.

Are investors shorting Orthopediatrics?

Orthopediatrics saw a decrease in short interest during the month of August. As of August 14th, there was short interest totaling 1,720,000 shares, a decrease of 16.1% from the July 30th total of 2,050,000 shares. Based on an average trading volume of 150,100 shares, the days-to-cover ratio is presently 11.5 days. Currently, 12.7% of the shares of the stock are short sold.
View Orthopediatrics' Short Interest
.

Who are some of Orthopediatrics' key competitors?

What other stocks do shareholders of Orthopediatrics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthopediatrics investors own include AbbVie (ABBV), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Intel (INTC), Advanced Micro Devices (AMD), Crispr Therapeutics (CRSP), Cisco Systems (CSCO), Walt Disney (DIS), Editas Medicine (EDIT) and Enterprise Products Partners (EPD).

Who are Orthopediatrics' key executives?

Orthopediatrics' management team includes the following people:
  • Mr. Mark C. Throdahl, Pres, CEO & Director (Age 68)
  • Mr. Fred L. Hite, CFO & Director (Age 51)
  • Mr. Daniel J. Gerritzen, VP of Legal & HR, Gen. Counsel and Sec. (Age 49)
  • Mr. David R. Bailey, Exec. VP (Age 40)
  • Mr. Gregory A. Odle, Exec. VP of Commercialization (Age 49)

When did Orthopediatrics IPO?

(KIDS) raised $52 million in an initial public offering on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers.

What is Orthopediatrics' stock symbol?

Orthopediatrics trades on the NASDAQ under the ticker symbol "KIDS."

Who are Orthopediatrics' major shareholders?

Orthopediatrics' stock is owned by many different institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (5.30%), Vanguard Group Inc. (3.36%), Driehaus Capital Management LLC (2.86%), FMR LLC (2.44%), Summit Partners Public Asset Management LLC (2.39%) and Wasatch Advisors Inc. (2.07%). Company insiders that own Orthopediatrics stock include Bernie B Berry III, David R Bailey, Gregory A Odle, Mark C Throdahl and Stephen F Burns.
View institutional ownership trends for Orthopediatrics
.

Which major investors are selling Orthopediatrics stock?

KIDS stock was sold by a variety of institutional investors in the last quarter, including EAM Investors LLC, CWM LLC, Summit Partners Public Asset Management LLC, Goldman Sachs Group Inc., Oak Ridge Investments LLC, UBS Group AG, Baird Financial Group Inc., and US Bancorp DE. Company insiders that have sold Orthopediatrics company stock in the last year include Bernie B Berry III, David R Bailey, Gregory A Odle, Mark C Throdahl, and Stephen F Burns.
View insider buying and selling activity for Orthopediatrics
.

Which major investors are buying Orthopediatrics stock?

KIDS stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Riverbridge Partners LLC, Wasatch Advisors Inc., Vanguard Group Inc., Federated Hermes Inc., Mutual of America Capital Management LLC, Driehaus Capital Management LLC, and Alyeska Investment Group L.P..
View insider buying and selling activity for Orthopediatrics
.

How do I buy shares of Orthopediatrics?

Shares of KIDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Orthopediatrics' stock price today?

One share of KIDS stock can currently be purchased for approximately $40.77.

How big of a company is Orthopediatrics?

Orthopediatrics has a market capitalization of $797.01 million and generates $72.55 million in revenue each year. The company earns $-13,730,000.00 in net income (profit) each year or ($0.87) on an earnings per share basis. Orthopediatrics employs 80 workers across the globe.

What is Orthopediatrics' official website?

The official website for Orthopediatrics is www.orthopediatrics.com.

How can I contact Orthopediatrics?

Orthopediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The company can be reached via phone at 574-268-6379 or via email at [email protected]

This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.